Search Results - "Bilgin Doğan, Nazile"

Impact of anxiety level on circadian rhythm of blood pressure in hypertensive patients by Özpelit, Mehmet Emre, Özpelit, Ebru, Doğan, Nazile Bilgin, Pekel, Nihat, Ozyurtlu, Ferhat, Yılmaz, Akar, Saygı, Serkan, Tengiz, İstemihan, Ercan, Ertugrul

“…Considering the high prevalence rates and growing incidences of hypertension (HT) and anxiety disorders in the modern world, a full understanding of anxiety's…”
Get full text

The effects of chronic usage of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on contrast-induced nephropathy in low-risk patients [corrected] by Barış, Nezihi, Özpelit, Ebru, Doğan, Nazile Bilgin, Kangül, Hande, Gül, Sefa, Akdeniz, Bahri, Güneri, Sema

“…There is conflicting data about the role of renin- angiotensin- aldosterone system (RAAS) blockers in contrast-induced nephropathy (CIN) pathophysiology. In…”
Get full text

The Missing STEMIs and Lifestyle Changes During the COVID-19 Pandemic by Bilgin Dogan, Nazile, Ozel, Erdem

Get full text

Demographics of patients with heart failure who were over 80 years old and were admitted to the cardiology clinics in Turkey by Gök, Gülay, Zoghi, Mehdi, Sinan, Ümit Yaşar, Kılıç, Salih, Tokgözoğlu, Lale

“…Heart failure (HF) has a high prevalence and mortality rate in elderly patients; however, there are few studies that have focused on patients older than 80…”
Get full text

Cardioprotective Effects of Sodium-Glucose Cotransporter 2 Inhibitors and Their Possible Association With Normalization of the Circadian Index of Heart Rhythm by Dogan, Nazile Bilgin, Yasar, Hamiyet Yilmaz, Kilicaslan, Baris

“…Updated recommendations for the treatment of heart failure with reduced ejection fraction (HFrEF) include sodium-glucose cotransporter 2 (SGLT2) inhibitors and…”
Get full text

Peripartum cardiomyopathy: a case report by Gezer, Cenk, Ekin, Atalay, Özeren, Mehmet, Taner, Cüneyt Eftal, Bilgin Doğan, Nazile, Doğan, Aşkın

Get full text

Simple clinical risk score for no-reflow prediction in patients undergoing primary Percutaneous Coronary Intervention with acute STEMI by Dogan, Nazile Bilgin, Ozpelit, Ebru, Akdeniz, Selma, Bilgin, Muzaffer, Baris, Nezihi

“…To identify the STEMI patients at high risk in terms of no-reflow during percutaneous coronary intervention (PCI) with a simple risk score system that can be…”
Get full text

St Yükselmeli Miyokard Enfarktüsünde Primer Veya Kurtarıcı Perkütan Girişim Öncesi No-Reflow Fenomeni Öngörülebilir Mi? by Doğan, Nazile Bilgin

“…Giriş ve Amaç:Perkütan koroner girişimlerde koroner arterde akımı engelleyen diseksiyon, mekanik engel, distal emboli olmaksızın sorumlu arterin açılmasına…”
Get full text

The effects of chronic usage of enzyme inhibitors and angiotensin receptor blockers on contrast-induced nephropathy in low-risk patients/Düsük riskli hastalarda anjiyotensin dönüstürücü enzim inhibitörleri ve anjiyotensin reseptör blokerlerinin kronik kullaniminin kontrast madde nefropatisi üzerine etkileri by Baris, Nezihi, Özpelit, Ebru, Dogan, Nazile Bilgin, Kangül, Hande, Gül, Sefa, Akdeniz, Bahri, Güneri, Sema

Get full text

The effects of chronic usage of enzyme inhibitors and angiotensin receptor blockers on contrast-induced nephropathy in low-risk patients/ Dusuk riskli hastalarda anjiyotensin donusturucu enzim inhibitorleri ve anjiyotensin reseptor blokerlerinin kronik kullaniminin kontrast madde nefropatisi uzerine etkileri by Baris, Nezihi, Ozpelit, Ebru, Dogan, Nazile Bilgin, Kangul, Hande, Gul, Sefa, Akdeniz, Bahri, Guneri, Sema

“…Objective: There is conflicting data about the role of renin- angiotensin- aldosterone system (RAAS) blockers in contrast-induced nephropathy (CIN)…”
Get full text